High-dose methylprednisolone prevents vasospasm after subarachnoid hemorrhage through inhibition of protein kinase C activation

References

• Chyatte D, Rusch N, Sundt TM Jr. Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylpredniso lone. J Neurosurg 1983; 59: 925–932
   PubMed Web of Science ®Google Scholar
• Chyatte D, Fode NC, Nichols DA, Sundt TM Jr. Preliminary report: Effects of high-dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1987; 21: 157–160
   PubMed Web of Science ®Google Scholar
• Lombardi D, Gaetani P, Marcatico F, Cafe C, Rodriguez Y, Baena R. Effect of high-dose methylprednisoloneon anti-oxidantenzymes after experimental SAH. J Neurol Sci 1992; 111: 13–19
   PubMed Web of Science ®Google Scholar
• Peterson JW, Kwun BD, Teramura A, Hackett JD, Morgan JA, Nishizawa 5, Bun T, Zervas NT. Immunological reaction against human subarachnoid erythrocyte.A model for the onset of cerebral vasospasm after subarachnoid hemorrhage. JNeurosurg 1989; 71: 718–726
   PubMed Web of Science ®Google Scholar
• Peterson JW, Kwun BD, Hackett JD, Zervas NT. The role of inflammation in experimental cerebral vasospasm. J Neurosurg 1990; 72: 767–774
   PubMed Web of Science ®Google Scholar
• Suzuki 5, Ogane K, Souma M, Ohkuma H, lwabuchi T. Efficacy of steroid hormone in solution for intracranial irrigation during aneurysmal surgery for prevention of the vasospasm syndrome. Acta Neurochirur 1994; 131: 184–188
   PubMed Web of Science ®Google Scholar
• Peterson JW, Nishizawa 5, Hackett JD, Bun T, Teramura A, Zervas NT. Cyclosporine A reduces cerebral vasospasm after subarach-noid hemorrhage in dogs. Stroke 1990; 21: 133–137
   PubMed Web of Science ®Google Scholar
• Nishizawa 5, Peterson JW, Shimoyama I, Iwasaki K, Uemura K. Therapeutic effect of a new immunosuppressant, FK-506, on vasospasm after subarachnoid hemorrhage. Neurosurgery 1993; 32: 986–992
   PubMed Web of Science ®Google Scholar
• Yamakawa K, Sasaki T, Tsubaki 5, Nakagomi T, Saito I, Takakura K. Effect of high-dose methylprednisolone on vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1991; 31: 24–31
   PubMedGoogle Scholar
• Nishizawa 5, Peterson JW, Shimoyama I, Uemura K. Relation between protein kinase C and calmodu lin systems in cerebro-vascular contraction: Investigation of the pathogenesis of vaso-spasm after subarachnoid hemorrhage. Neurosurgery 1992; 31: 711–716
   PubMed Web of Science ®Google Scholar
• Nishizawa 5, Nezu N, Uemura K. Direct evidencefor a key role of protein kinase C in the development of vasospasm after sub-arachnoid hemorrhage. JNeurosurg 1992; 76: 635–639
   PubMed Web of Science ®Google Scholar
• Nishizawa 5, Yamamoto 5, Yokoyama T, Ryu H, Uemura K. Chronological changes of arterial diameter, cGMP, and protein kinase C in the development of vasospasm. Stroke 1995; 26: 1916–1921
   PubMed Web of Science ®Google Scholar
• Nishizawa 5, Yamamoto 5, Uemura K. Inter-relation between protein kinase C and nitric oxide in the developmentof vasospasm after subarachnoid hemorrhage. Neurol Res 1996; 18: 89–95
   PubMed Web of Science ®Google Scholar
• Nishizawa 5, Yamamoto 5, Yokoyama T, Uemura K. Dysfunction of nitric oxide induces protein kinase C activation resulting in vasospasm after subarachnoid hemorrhage. Neurol Res 1997 19: 558–562
   PubMed Web of Science ®Google Scholar
• Nishizawa 5, Yokota N, Yokoyama T, Uemura K. Obligatory roles of protein kinase C and nitric oxide in the regulation of cerebral vascular tone: An implication of a pathogenesis of vasospasm after subarachnoid hemorrhage. Acta Neurochir (Wien) 1998; 140: 1063–1068
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 1984; 308: 693–698
   PubMed Web of Science ®Google Scholar
• Varsos VG, Liszczak TM, Han DH, Kistler JP, Vielma J, Black PM, Heros RC, Zervas NT. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a ‘two-hemorrhage’ canine model. J Neurosurg 1983; 58: 11–17
   PubMed Web of Science ®Google Scholar
• McGinley PA, Braughler JM, Hall ED. Determination of methyl-prednisolone in central nervous tissue and plasma using normal-phase high-performance liquid chromatography. JChromatography 1982; 230: 29–35
   PubMed Web of Science ®Google Scholar
• Nakayama K. Active and passive mechan ica I properties of ring and spiral segments of isolated dog basilar artery assessed by electrical and pharmacological stimulations. Blood Vessels 1988; 25: 285-298
   Google Scholar
• Kawamata T, Peterson JW, Bun T, Zervas NT. Augmentation of both hemolysate-induced contraction and activation of protein kinase C by submaxim um activation in canine cerebral arteries in vitro. J Neurosurg 1997; 87: 908–915
   PubMed Web of Science ®Google Scholar
• Steinke DE, Weir BKA, Findlay JM, Tanabe T, Grace M, Krushelnycky BW. A trial of the non-glucocorticoid 21-amino-steroid U74-6F on experimentalcerebral vasospasm. Neurosurgery 1989; 24: 179–186
   PubMed Web of Science ®Google Scholar
• Zuccarello M, Arsch JT, Schmitt G, Woodward J, Anderson DK. Effect of the 21-am inosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage. JNeurosurg 1989; 71: 98–104
   PubMed Web of Science ®Google Scholar
• Haley EC, Kassell NF, Apperson-Hansen C, Ma ile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad myselate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America. I Neurosurg 1997; 86: 467–474
   PubMed Web of Science ®Google Scholar
• Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM. Double-blind, random-ized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. Neurosurg 1999; 90: 1011–1017
   Web of Science ®Google Scholar
• Lanzino G, Kassell NF. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperativestudy in North America. JNeurosurg 1999; 90: 1018–1024
   PubMed Web of Science ®Google Scholar
• Fleishaker JC, Peters GR, Cathcart KS. Evaluation of the pharmaco-kinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger. I: Single-dose administration. J Clin Pharmacol 1993; 33: 175–181
   PubMed Web of Science ®Google Scholar
• Fleishaker JC, Peters GR, Cathcart KS, Steenwyk RC. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger. II: Multiple-dose admini-stration. JClin Pharmaco 11993; 33: 182-190
   Google Scholar
• Fleishaker JC, Hulst LK, Peters GR. The effect of phenytoin on the pharmacokinetics of tirilazad mesylate in healthy male volunteers. Clin Pharmacol Ther 1994; 56: 389–397
   PubMed Web of Science ®Google Scholar